Chester County News and Community Website
MALVERN, PA — HMP Global has unveiled Evolution Plus, a new streaming service that offers exclusive, on-demand psychotherapy education for mental health professionals. This service serves as a digital companion to …
HMP Global Launches Evolution Plus for Psychotherapy Education Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved the Shield test, developed by Guardant Health, Inc., for colorectal cancer (CRC) screening. This test uses blood collected in …
FDA Approves Guardant Health Blood Test for Colorectal Cancer Screening Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently published a critical piece by Commissioner Robert M. Califf, M.D., titled “From Awareness to Action: Tackling the Rising Burden …
FDA Commissioner Highlights Rising Burden of Chronic Diseases Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has received approval from the U.S. Food and Drug Administration (FDA) to transition to a new solid form of buntanetap in future …
Annovis Bio Gains FDA Approval for New Form of Neurodegenerative Drug Read More
WASHINGTON, D.C. — On Tuesday, the Food and Drug Administration (FDA) updated its advisory on an E. coli outbreak linked to bulk organic walnuts. The outbreak, traced to Gibson Farms, …
FDA Closes Investigation into E. Coli Outbreak Linked to Organic Walnuts Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) reports that a dairy farm worker in Colorado has been diagnosed with avian influenza A(H5), marking the state’s first …
Colorado Reports First Human Case of Avian Influenza Amid Multistate Outbreak Read More
WASHINGTON, D.C. — On Monday, the FDA’s Center for Devices and Radiological Health (CDRH) announced the continued expansion of its Total Product Life Cycle (TPLC) Advisory Program. This program, initially …
FDA Expands Total Product Life Cycle Advisory Program to Accelerate Medical Device Development Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved Iqirvo (elafibranor) oral tablets to treat primary biliary cholangitis (PBC). This rare autoimmune disease causes inflammation and damage …
FDA Approves New Treatment for Rare Liver Disease Read More